-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Export Stocks That Could Gain From The India New Zealand Trade Deal

Simply Wall St·09/16/2026 17:28:59
Listen to the news

India and New Zealand just rewrote the trade rulebook, and that matters for your portfolio more than any single quarterly result. As tariffs fade on a wide mix of exports, some exporters suddenly face a wider customer base and fatter potential margins, while others confront sharper competition on their home turf. This article walks through three stocks tied to this new reality, how the free trade deal touches their businesses, and what that could mean for investors watching India and New Zealand trade more closely.

The stocks profiled below are only a small sample of what this trade reset touches. The full screen surfaces 23 more India and New Zealand exporters whose stories are just as compelling but not covered here. To go straight to the wider opportunity set, use the India–New Zealand Trade-Exposed Exporters screener to identify, filter and analyze the trade exposed businesses that best fit your own conviction.

a2 Milk (NZSE:ATM)

Overview: a2 Milk sells A2 protein branded infant formula and dairy products across Australia, New Zealand, China, wider Asia and the United States, positioning it firmly as an export-focused New Zealand dairy player.

Operations: The group generates about NZ$1.45b from China and other Asia, NZ$346 million from Australia and New Zealand, and NZ$179 million from the USA.

Market Cap: NZ$6.21b

a2 Milk sits squarely in the India–New Zealand Trade-Exposed Exporters theme because it is already wired into Asian dairy demand. Any tariff relief into India therefore plugs straight into an existing export machine rather than a cold start.

"The company's expansion plans, including establishing additional China-label IMF registrations and developing new manufacturing capabilities, require considerable capital expenditure. This may impact future earnings if the return on investment is not as high as expected."

What happens to future margins and growth will hinge on how one unseen pressure in that expansion plan ultimately resolves.

That hidden pressure point is exactly what the full narrative for a2 Milk unpacks, mapping how capex, China exposure and India access could reshape a2 Milk's risk reward profile.

NZSE:ATM Revenue & Expenses Breakdown as at Sep 2026
NZSE:ATM Revenue & Expenses Breakdown as at Sep 2026

Parag Milk Foods (BSE:539889)

Overview: Parag Milk Foods is an Indian dairy producer focused on branded, value added products and exports across milk, cheese, ghee and nutrition.

Operations: Parag Milk Foods generates about ₹39.1b in revenue from processing milk and producing a wide range of dairy products.

Market Cap: ₹33.7b

Parag Milk Foods matters in this India–New Zealand Trade-Exposed Exporters theme because it already sells branded dairy and then layers export ambition on top.

"The Avvatar Protein Cold Coffee product is offered in India’s first Tetra Prisma Aseptic 250E pack and is positioned as an on-the-go beverage combining convenience, nutrition, and taste, with 15g protein per 250 ml pack and no added sugar or artificial sweeteners."

What happens if one quiet shift in how consumers treat everyday protein drinks ends up deciding Parag’s future pricing power and margins?

That quiet shift in everyday protein habits is exactly what the full narrative for Parag Milk Foods lays out, including how Parag Milk Foods could see pricing power accelerate or stall.

BSE:539889 Revenue & Expenses Breakdown as at Sep 2026
BSE:539889 Revenue & Expenses Breakdown as at Sep 2026

New Zealand King Salmon Investments (NZSE:NZK)

Overview: New Zealand King Salmon Investments farms, processes and exports premium salmon products worldwide, putting it squarely in the trade-exposed food exporter bucket.

Operations: The business generates about NZ$176.6 million from farming, processing, selling and distributing premium salmon, with revenue spread across New Zealand, North America, Australia, Asia and Europe.

Market Cap: NZ$123.8 million

New Zealand King Salmon Investments matters for this India–New Zealand exporters screen because it already runs a global seafood business that lives or dies on trade access, logistics costs and where each extra tonne of fish can be sold for the best price.

"The Blue Endeavour project, with significant funding from the New Zealand government, is expected to expand production capacity, potentially increasing revenues once the infrastructure is fully operational."

What happens to New Zealand King Salmon Investments' margins if one tightly managed production and market mix decision shifts even slightly in the wrong direction?

That inflection point is where the full narrative for New Zealand King Salmon Investments steps in, showing how production choices, pricing power and export mix could be quietly accelerating or stalling New Zealand King Salmon Investments.

NZSE:NZK Revenue & Expenses Breakdown as at Sep 2026
NZSE:NZK Revenue & Expenses Breakdown as at Sep 2026

Seeking Fresh Alternatives Before Others Do

Fresh opportunities can move quickly when momentum builds, prices rise and under the radar ideas attract broader attention. Review these themed lists while they may still be timely.

  • Spot potential turnarounds before the stories reach more investors by reviewing the 620 high quality undiscovered gems that are still under most investors’ radar.
  • Track structural demand in critical materials by following the 28 best rare earth metal stocks powering areas such as EV motors and high performance electronics.
  • Explore companies with a focus on cash returns in a world of changing prices by reviewing the 162 dividend fortresses built on solid income histories.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.